Health
Messenger RNA vaccines lower risk for asymptomatic infection, study finds – Healio
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world…
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world study results published in Clinical Infectious Diseases.
Even after one dose, the risk for asymptomatic infection was reduced by 79%, researchers reported. The two messenger RNA vaccines authorized for use in the United States are made by Pfizer-BioNTech and Moderna.
“As people are undergoing their routine care and they’re caring for…
-
General20 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
General23 hours agoBack-to-back rate cuts tipped when Reserve Bank meets
-
Noosa News22 hours agoWoman left with significant arm injuries in lion attack at Darling Downs Zoo in Queensland
-
General21 hours agoLithium mine closure shines light on Ravensthorpe community’s resilience